trending Market Intelligence /marketintelligence/en/news-insights/trending/ifgEzqgGTja5wA7BKBrA8w2 content esgSubNav
In This List

Heron Therapeutics CFO resigns

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Heron Therapeutics CFO resigns

Brian Drazba resigned as Heron Therapeutics Inc.'s CFO and vice president of finance, effective March 31.

The company accepted Drazba's resignation Sept. 30, 2016.

In connection with Drazba's departure, CEO Barry Quart became principal financial officer and principal accounting officer, effective April 1.